https://kkumar.exblog.jp/245256215/
Cendakimab Market Outlook 2034: Growth Trends, Forecast, and Key Insights : Stay Ahead in Pharma...
The biopharmaceutical landscape is witnessing significant advancements in imm...
https://hsrc.himmelfarb.gwu.edu/gwhpubs/5549/
"Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Ra" by Andrew Blauvelt, Emma...
IMPORTANCE: Cendakimab selectively targets interleukin (IL)-13, a type 2 cytokine implicated in atopic dermatitis (AD) pathogenesis, by inhibiting binding to...